rs13104811
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs13104811(A;A) |
Make rs13104811(A;G) |
Make rs13104811(G;G) |
Reference | GRCh38.p7 38.3/151 |
Chromosome | 4 |
Position | 74529595 |
is a | snp |
is | mentioned by |
dbSNP | rs13104811 |
dbSNP (classic) | rs13104811 |
ClinGen | rs13104811 |
ebi | rs13104811 |
HLI | rs13104811 |
Exac | rs13104811 |
Gnomad | rs13104811 |
Varsome | rs13104811 |
LitVar | rs13104811 |
Map | rs13104811 |
PheGenI | rs13104811 |
Biobank | rs13104811 |
1000 genomes | rs13104811 |
hgdp | rs13104811 |
ensembl | rs13104811 |
geneview | rs13104811 |
scholar | rs13104811 |
rs13104811 | |
pharmgkb | rs13104811 |
gwascentral | rs13104811 |
openSNP | rs13104811 |
23andMe | rs13104811 |
SNPshot | rs13104811 |
SNPdbe | rs13104811 |
MSV3d | rs13104811 |
GWAS Ctlg | rs13104811 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 29771169] Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.